Featured
Last news
Sean Combs: music pioneer, entrepreneur -- and convicted felon
Even during his federal criminal trial in New York, the descriptions of Sean Combs were frequently those of awe: one former assistant called him "a god among men."
Organic Produce Summit Returns This July 2025, Unveiling an Ambitious and Forward-Thinking Agenda Designed to Revolutionize the Organic Industry
The highly anticipated Organic Produce Summit, the industry's premier event, is set to host over 200 organic growers, shippers and processors and 300 influential retailers and buyers to shape the future of sustainable agriculture.
MDCE's RGU Explodes in Popularity, Patent Pending Status Weeks Away
Viral demand for Real Game Used's AI authentication drives record submission volume as the company advances toward patent pending status and expands partnerships with major entertainment auction brands.
UTILITY Therapeutics Announces Acquisition by Alembic Pharmaceuticals Inc.
Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated urinary tract infectionsPIVYA expected to be available in the U.S. in the 4th quarter of 2025.
LQR House Announces Third Purchase Order for the Ontario Marketplace by of the Earth Distribution
Demonstrating sustained growth and demand in the Canadian market
MIRA Reports Potent Inflammatory Pain Relief from Non-Psychoactive Marijuana Analog Mira-55 in Animal Model, Matching Morphine Without Opioid Risks
With Mira-55 and Ketamir-2, MIRA is advancing complementary non-opioid therapies for two of the largest pain markets
Tears, prayers, exultation: Diddy radiates relief after partial acquittal
His gaze to the ceiling in exultation and hands miming prayer, Sean Combs appeared overjoyed as the jury foreman cleared the music mogul's name of sweeping charges that took a life-sentence in prison off the table.
French court convicts ex-Ubisoft bosses for workplace harassment
A French court sentenced three former Ubisoft executives on Wednesday to suspended prison terms for enabling a culture of sexual and psychological harassment at the gaming giant.
Dalai Lama says he will have successor after his death
The exiled spiritual leader of Tibet confirmed Wednesday that he will have a successor when he dies, reassuring Buddhist followers around the globe that the 600-year-old institution of the Dalai Lama will continue.
Australian airline Qantas says hit by 'significant' cyberattack
Australian airline Qantas said Wednesday it was investigating a "significant" cyberattack, after hackers infiltrated a system containing sensitive data on six million customers.
Thai veteran politician set for single day as acting PM
Thailand's acting prime minister is set to helm the country for only one full day Wednesday, standing in for suspended premier Paetongtarn Shinawatra before being replaced himself in a cabinet reshuffle.
Son of kingpin 'El Chapo' to plead guilty to drug trafficking in US
A son of Mexican drug kingpin Joaquin "El Chapo" Guzman has agreed to plead guilty to drug trafficking in the United States as part of a plea deal, court documents show.
Xebra Brands Ltd. Terminates Letter of Intent to Acquire BSK Holdings Inc.; Announces Delay in Completion of Annual Filings and MCTO; Announces Loan
Continued Partnership to Bring ELEMENTS™ CBD Product Line to U.S. Market
Onco-Innovations CEO Highlights Strategic Milestones and R&D Progress in Special Investors' Conference Call
VANCOUVER, BC / ACCESS Newswire / July 2, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that on July 2, 2025, its Chief Executive Officer, Thomas O'Shaughnessy, held an investor call during which he provided shareholders with an update on the Company's strategic milestones and development roadmap, as it continues to advance its mission to accelerate cancer treatment innovation through cutting-edge therapeutics and artificial intelligence.
Pivotree Inc. Announces Results from its Annual and Special Meeting of Shareholders
TORONTO, ONTARIO / ACCESS Newswire / July 2, 2025 / Pivotree Inc. (TSXV:PVT) ("Pivotree"), a leading provider of frictionless commerce solutions and services, announced today the results of its annual and special meeting of shareholders held on June 25, 2025 (the "Meeting"). All of the resolutions proposed, as set out in the Company's management information circular dated May 2, 2025 (the "Management Information Circular"), were duly passed by the shareholders of the Company and ratified at the Meeting.
"Path of Liberty: That Which Unites US" Honors Veterans on July 4th as the Nation Begins the Countdown to America's 250th Birthday
Path of Liberty will offer active, off-duty, and retired military members and their families special complimentary tickets for prime viewing.
The National Law Review Expands Scope of Legal Notices
Leading Online Legal Publication Expands Public Notice Section
MDCE to Cancel 680 Million CEO Shares and Slash 980 Million Authorized Shares as Stock Trades Near 52-Week Low; Q2 Rebound Underway
Massive 1.66 Billion Share Reduction Signals Long-Term Commitment to Shareholder Value as Company Prepares to Report Q2 Rebound Performance
Viemed Completes Acquisition of Lehan's Medical Equipment Anticipates Updating its Full Year 2025 Outlook for the Acquisition with Second Quarter 2025 Financial Results
LAFAYETTE, LA / ACCESS Newswire / July 2, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ: VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced that it has completed the previously disclosed acquisition of Illinois-based Lehan's Medical Equipment ("Lehan") for a base purchase price of $26 million, subject to customary adjustments, plus estimated contingent payments of $2.2 million.
Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market
FORT LAUDERDALE, FL / ACCESS Newswire / July 2, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its wholly owned Canadian subsidiary, Nora Pharma Inc., has launched NIOPEG®, the Company's first Biosimilar drug on the market.
Bausch Health to Announce Second Quarter 2025 Results on July 30
LAVAL, QC / ACCESS Newswire / July 2, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2025 financial results after market close on Wednesday, July 30, 2025. Bausch Health will host a conference call and live webcast at 5:00 p.m. U.S. EDT to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
DEA Architect of Marijuana Obstruction Matthew Strait Retires - Who Cleans Up His Marijuana Policy Mess?
The DEA's in-house administrative court system has been dealt a severe blow by recent U.S. Supreme Court rulings. Axon v. FTC (2023) and Jarkesy v. SEC (2024) have unequivocally declared this system unconstitutional, effectively rendering years of DEA imposed delays and administrative hearings illegitimate. In a significant move, the Department of Justice has formally refused to defend this unconstitutional system, potentially exposing current and former DEA leadership to civil rights litigation and heightened judicial oversight.
Partial verdict in Combs trial, jury will keep deliberating
A jury reached a partial verdict Tuesday in the sex trafficking trial of Sean "Diddy" Combs, but the panel was as of yet unable to agree on the most serious charge facing the music mogul -- racketeering.
Jury reaches partial verdict in Sean "Diddy" Combs trial
A jury reached a partial verdict Tuesday in the sex trafficking trial of Sean "Diddy" Combs but has been unable to agree on the most serious charge facing the music mogul -- racketeering.
AI videos push Combs trial misinformation, researchers say
Around two dozen YouTube channels are pumping out AI-generated videos with false claims about music mogul Sean "Diddy" Combs's sex trafficking trial, racking up millions of views and profiting from misinformation, researchers say.
French paparazzi boss handed 18-month suspended sentence for blackmail
A French court on Tuesday sentenced paparazzi queen Mimi Marchand to an 18-month suspended prison sentence for blackmailing a TV host, saying she had "contempt" for her victim.
'Remember Charlie Hebdo!' Protesters seethe at Istanbul magazine
Angry protesters rallied in Istanbul on Tuesday despite a heavy police presence, shouting threats following allegations a satirical magazine published a cartoon of the Prophet Mohammed.
The Power of Collaboration: Jason Binn's Strategic Partnerships with Luxury Giants
NEW YORK, NY / ACCESS Newswire / July 1, 2025 / In true DuJour fashion, media mogul and cultural tastemaker Jason Binn returned to Art Basel Miami Beach with another unforgettable event that blended art, fashion, celebrity, and innovation in a way only he can.
Golden Retriever and Goldendoodle Breeder, Golden Puppies, Donates Puppy as a Service Dog
Golden Puppies, a Louisiana-based Golden Retriever and Goldendoodle breeder, announces donation of a Goldendoodle puppy to American Red Cross volunteer
ASTCT’s Leadership Contributes to FDA Decision to Eliminate REMS for BCMA- and CD19-Directed Autologous CAR T Cell Immunotherapies
CHICAGO, IL / ACCESS Newswire / July 1, 2025 / The U.S. Food and Drug Administration (FDA) has removed the Risk Evaluation and Mitigation Strategies (REMS) requirements for currently approved B-cell maturation antigen (BCMA)- and CD19-directed autologous chimeric antigen receptor (CAR) T cell therapies. The American Society for Transplantation and Cellular Therapy (ASTCT) contributed to this policy change, in part, by a 2023 multidisciplinary workshop hosted by ASTCT's 80/20 Subcommittee of the Committee on Cellular Therapy.
RETRANSMISSION: Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.
Underfollowed Innovator to Enjoy Profile Raise
New Horizon Medical Solutions Adds AmchoPlast(TM) to its Industry-Best Product Portfolio
Next‑Gen Amnio-Chorionic Membrane for Enhanced Wound Care is Latest Offering in a Slew of New Products Focused on Increasing Patient Care